MUC1 and neoplasm: Dai et al. developed a chimera named Chi-29b, comprising a MUC1 aptamer that specifically targeted the MUC1 protein on the surface of tumor cells, along with miR-29b, which inhibited the expression of DNA methyltransferases (DNMTs) and subsequently restored the expression of the PTEN gene (Figure 3B).